DESyne in Routine Clinical Practice
IRIS DESYNE
Evaluation of Effectiveness and Safety of DESyne in Routine Clinical Practice; A Multicenter, Prospective Observational Study
1 other identifier
observational
342
1 country
20
Brief Summary
The purpose of this study is to evaluate effectiveness and safety of DESyne in Routine Clinical Practice
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2014
Typical duration for all trials
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2014
CompletedFirst Posted
Study publicly available on registry
January 20, 2014
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedSeptember 13, 2021
September 1, 2021
3.7 years
January 16, 2014
September 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite event rate
Death, non fatal myocardial infarction, Target Vessel Revascularization
1year
Secondary Outcomes (10)
All death
5year
Cardiac death
5year
Myocardial infarction
5year
Composite event of death or myocardial infarction
5year
Composite event of cardiac death or myocardial infarction
5year
- +5 more secondary outcomes
Study Arms (1)
IRIS DeSyne
DeSyne drug eluting stent group
Interventions
Eligibility Criteria
patients with DeSyne stent
You may qualify if:
- Age 20 and more
- Intervention with DeSyne drug eluting coronary stent
- Agreed with written informed consent form
You may not qualify if:
- Intervention with DeSyne drug eluting coronary stent and other drug eluting stent at the same time
- Life expectancy of 1year and under
- Cardiac shock
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seung-Jung Parklead
- CardioVascular Research Foundation, Koreacollaborator
- Amg Korea Co. Ltd.collaborator
Study Sites (20)
Sam Anyang Hospital
Anyang, South Korea
Soon Chun Hyang University Hospital Bucheon
Cheonan, South Korea
Chungbuk National University Hospital
Cheongju-si, South Korea
Hallym University Chuncheon Sacred Heart Hospital
Chuncheon, South Korea
Kangwon National University Hospital
Chuncheon, South Korea
Konkuk University Chungju hospital
Chungju, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
Gangneung Asan Hospital
Gangneung, South Korea
Chonnam National University Hospital
Gwangju, South Korea
Gachon University Gil Hospital
Incheon, South Korea
Kwangju Christian Hospital
Kwangju, South Korea
Asan Medical Center
Seoul, South Korea
Gangnam Severance Hospital
Seoul, South Korea
Kangdong Sacred Heart Hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Seoul Veterans Hospital
Seoul, South Korea
St.carollo Hospital
Suncheon, South Korea
Ulsan University Hospital
Ulsan, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD,PhD
Study Record Dates
First Submitted
January 16, 2014
First Posted
January 20, 2014
Study Start
July 1, 2014
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
September 13, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
This is not a publicly funded trial.